154 related articles for article (PubMed ID: 21869889)
1. A Cohort Study of p53 Mutations and Protein Accumulation in Benign Breast Tissue and Subsequent Breast Cancer Risk.
Kabat GC; Kandel RA; Glass AG; Jones JG; Olson N; Duggan C; Ginsberg M; Negassa A; Rohan TE
J Oncol; 2011; 2011():970804. PubMed ID: 21869889
[TBL] [Abstract][Full Text] [Related]
2. p53 Alterations and protein accumulation in benign breast tissue and breast cancer risk: a cohort study.
Rohan TE; Li SQ; Hartwick R; Kandel RA
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1316-23. PubMed ID: 16835330
[TBL] [Abstract][Full Text] [Related]
3. p53 protein accumulation and mutations in normal and benign breast tissue.
Kandel R; Li SQ; Ozcelik H; Rohan T
Int J Cancer; 2000 Jul; 87(1):73-8. PubMed ID: 10861455
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of c-erbB-2 and p53 in benign breast disease and breast cancer risk.
Rohan TE; Hartwick W; Miller AB; Kandel RA
J Natl Cancer Inst; 1998 Sep; 90(17):1262-9. PubMed ID: 9731732
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for breast cancer in women biopsied for benign breast disease: a nested case-control study.
Kabat GC; Jones JG; Olson N; Negassa A; Duggan C; Ginsberg M; Kandel RA; Glass AG; Rohan TE
Cancer Epidemiol; 2010 Feb; 34(1):34-9. PubMed ID: 20079704
[TBL] [Abstract][Full Text] [Related]
6. Infiltrating immune cells in benign breast disease and risk of subsequent invasive breast cancer.
Rohan TE; Arthur R; Wang Y; Weinmann S; Ginsberg M; Loi S; Salgado R
Breast Cancer Res; 2021 Jan; 23(1):15. PubMed ID: 33516237
[TBL] [Abstract][Full Text] [Related]
7. Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study.
Høyer AP; Gerdes AM; Jørgensen T; Rank F; Hartvig HB
Breast Cancer Res Treat; 2002 Jan; 71(1):59-65. PubMed ID: 11859874
[TBL] [Abstract][Full Text] [Related]
8. Reproductive factors in relation to breast cancer characterized by p53 protein expression (United States).
Furberg H; Millikan RC; Geradts J; Gammon MD; Dressler LG; Ambrosone CB; Newman B
Cancer Causes Control; 2003 Sep; 14(7):609-18. PubMed ID: 14575358
[TBL] [Abstract][Full Text] [Related]
9. Cigarette smoking and other risk factors in relation to p53 expression in breast cancer among young women.
Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):255-63. PubMed ID: 10090304
[TBL] [Abstract][Full Text] [Related]
10. Environmental factors in relation to breast cancer characterized by p53 protein expression.
Furberg H; Millikan RC; Geradts J; Gammon MD; Dressler LG; Ambrosone CB; Newman B
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):829-35. PubMed ID: 12223426
[TBL] [Abstract][Full Text] [Related]
11. Mutations in p53, p53 protein overexpression and breast cancer survival.
Rossner P; Gammon MD; Zhang YJ; Terry MB; Hibshoosh H; Memeo L; Mansukhani M; Long CM; Garbowski G; Agrawal M; Kalra TS; Gaudet MM; Teitelbaum SL; Neugut AI; Santella RM
J Cell Mol Med; 2009 Sep; 13(9B):3847-57. PubMed ID: 19602056
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 protein overexpression and gene amplification in benign breast tissue and breast cancer risk.
Kandel R; Zhu XL; Li SQ; Rohan T
Eur J Cancer Prev; 2001 Feb; 10(1):43-51. PubMed ID: 11263590
[TBL] [Abstract][Full Text] [Related]
13. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer.
Schildkraut JM; Bastos E; Berchuck A
J Natl Cancer Inst; 1997 Jul; 89(13):932-8. PubMed ID: 9214672
[TBL] [Abstract][Full Text] [Related]
14. p53 mutations in benign breast tissue.
Millikan R; Hulka B; Thor A; Zhang Y; Edgerton S; Zhang X; Pei H; He M; Wold L; Melton LJ
J Clin Oncol; 1995 Sep; 13(9):2293-300. PubMed ID: 7666086
[TBL] [Abstract][Full Text] [Related]
15. Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility.
Liu J; Tang X; Li M; Lu C; Shi J; Zhou L; Yuan Q; Yang M
Breast Cancer Res Treat; 2013 Jul; 140(1):151-7. PubMed ID: 23793604
[TBL] [Abstract][Full Text] [Related]
16. p53 mutations and expression in breast carcinoma in situ.
Lukas J; Niu N; Press MF
Am J Pathol; 2000 Jan; 156(1):183-91. PubMed ID: 10623666
[TBL] [Abstract][Full Text] [Related]
17. TP53 (rs1042522, rs28934571) and TP21 (rs1801270, rs1059234) Polymorphisms and Risk of Breast Cancer among Rural Women of Maharashtra: Findings from a Hospital Based Case- Control Study.
Datkhile KD; Bhosale SJ; Durgawale PP; Jagdale NJ; More AL; Gudur RA; Gudur AK; Patil SR
Asian Pac J Cancer Prev; 2023 May; 24(5):1611-1619. PubMed ID: 37247280
[TBL] [Abstract][Full Text] [Related]
18. Pre-diagnostic circulating p53 autoantibodies and subsequent lung cancer risk in low-income African and European Americans.
Yoon HS; Zheng W; Cai H; Wu J; Shidal C; Wang J; Shu XO; Waterboer T; Blot WJ; Cai Q
Cancer Epidemiol; 2022 Dec; 81():102288. PubMed ID: 36332502
[TBL] [Abstract][Full Text] [Related]
19. Role of GSTM1 (Null/Present), GSTP1 (Ile105Val) and P53 (Arg72Pro) genetic polymorphisms and the risk of breast cancer: a case control study from South India.
Samson M; Swaminathan R; Rama R; Sridevi V; Nancy KN; Rajkumar T
Asian Pac J Cancer Prev; 2007; 8(2):253-7. PubMed ID: 17696741
[TBL] [Abstract][Full Text] [Related]
20. Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population.
Franeková M; Zúbor P; Stanclová A; Dussan CA; Bohusová T; Galo S; Dobrota D; Kajo K; Péc M; Racay P
Neoplasma; 2007; 54(2):155-61. PubMed ID: 17319790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
